Christian J. Maine, Ph.D.

Christian J. Maine, Ph.D. has worked in the field of immuno-oncology and related areas since 2010. In 2010, they began a postdoctoral role in the Laboratory of Dr. Linda Sherman at The Scripps Research Institute, where they investigated the role of the autoimmunity-associated gene, PTPN22, in immune tolerance and applied these findings to viral infection and tumor immunotherapy. In 2016, they moved to Fate Therapeutics Inc. as a Scientist in Immuno-oncology. In 2018, they joined Synthetic Genomics as the Oncology Vaccines Lead. In 2019, they moved to The Janssen Pharmaceutical Companies of Johnson & Johnson as the Research Project Lead in RNA Vaccines. In 2021, they joined Pfizer as the Translational Lead in Cancer Vaccines and Immunotherapeutics. Christian J. is currently working at Replicate Bioscience, Inc. as the Compound Development Team Lead in Immuno-oncology assets.

Christian J. Maine, Ph.D. began their education at Imperial College London in 2002, where they earned a BSc. in Biochemistry in 2005. Christian J. then pursued a MSc. in Immunology, which they completed in 2006. Christian J. continued their studies at Imperial College London, and in 2010 they earned a Ph.D. in Immunology.